Otsuka Pharmaceuticals
Otsuka and Lundbeck gain FDA approval for supplemental New Drug Application for dementia drug
May 11, 2023Medical Communications FDA, Lundbeck, Neurology, Otsuka Pharmaceuticals, alzheimer's disease, dementia
Japan-based healthcare company Otsuka Pharmaceutical and Danish pharma company Lundbeck have announced that the US Food and Drug Administration (FDA) …
NICE recommends Otsuka’s Lupkynis (voclosporin) in combination treatment for active lupus nephritis
May 4, 2023Medical Communications MHRA, NICE, Nephrology, Otsuka Pharmaceuticals, lupus nephritis
Otsuka Pharmaceuticals has announced that the National Institutes for Health and Care Excellence (NICE) has recommended Lupkynis (voclosporin) in combination …
Otsuka to acquire Neurovance in potential $250 million deal
March 6, 2017Sales and Marketing ADHD, Neurovance, Otsuka Pharmaceuticals
Otsuka Pharmaceuticals, a pharmaceutical firm with headquarters in Japan, has agreed to pay a potential $250 million in a deal …
